-
psnet.ahrq.gov/issue/safe-medication-prescribing-training-and-experience-medical-students-and-housestaff-large
December 22, 2008 - inconsistent use of safe prescribing practices, such as checking for drug allergies, assuring normal renal
-
psnet.ahrq.gov/issue/hcup-statistical-brief-313-trends-severe-maternal-morbidity-complications-patient
December 16, 2009 - Common acquired conditions identified include hemorrhage, sepsis , and respiratory and renal complications
-
psnet.ahrq.gov/issue/improving-your-office-testing-process-step-step-guide-rapid-cycle-patient-safety-and-quality
October 23, 2019 - September 27, 2017
AHRQ Safety Program for End-Stage Renal Disease Facilities—Toolkit
-
psnet.ahrq.gov/issue/improving-diagnosis-medicine-act-2022
December 21, 2022 - April 22, 2021
Hearing on Patient Safety and Quality Issues in End Stage Renal Disease
-
psnet.ahrq.gov/issue/developing-culture-safety-ambulatory-care-settings
July 19, 2023 - April 22, 2016
A 60-year-old man with delayed care for a renal mass.
-
psnet.ahrq.gov/web-mm/diuretics-and-electrolyte-abnormalities
February 15, 2017 - Thiazide diuretics act by reducing reabsorption of sodium (and chloride) in the distal renal tubules, … suddenly when edema is caused by heart failure exacerbation or deep vein thrombosis.( 7 ) In addition, her renal … diuretics for that matter, in treating edema of causes other than heart failure, liver disease, or renal
-
psnet.ahrq.gov/issue/medication-related-clinical-decision-support-alert-overrides-inpatients
July 16, 2019 - While nearly all duplicate drug alert and drug allergy overrides were appropriate, most renal or age
-
psnet.ahrq.gov/issue/identifying-and-prioritizing-educational-content-malpractice-claims-database-clinical
September 20, 2023 - The conditions represent common (e.g., eye infection), complex common (e.g., renal insufficiency, cardiovascular
-
psnet.ahrq.gov/issue/developing-high-value-care-programme-bottom-programme-faculty-resident-improvement-projects
December 16, 2020 - in reducing the unneeded intervention: fewer serum creatinine tests ordered in those with end stage renal
-
psnet.ahrq.gov/node/857260/psn-pdf
November 30, 2023 - co-transporter-2 inhibitors (SGLT2i).1,2 SGLT2i represent a class of medications that work
on the renal … acids, and ketone production.3,4
The use of SGLT2is in patients with diabetes, cardiovascular, and renal … SGLT2 inhibitor induced euglycemic DKA (EDKA) with
proximal renal tubular acidosis (RTA) as a rare fatal
-
psnet.ahrq.gov/issue/safe-practices-drug-allergies-using-cds-and-health-it
March 10, 2021 - Computerized clinical decision support during medication ordering for long-term care residents with renal
-
psnet.ahrq.gov/issue/concurrent-and-overlapping-surgeries-additional-measures-warranted
August 17, 2022 - December 19, 2012
Hearing on Patient Safety and Quality Issues in End Stage Renal Disease
-
psnet.ahrq.gov/issue/system-need-repair-addressing-organizational-failures-uss-organ-procurement-and
August 10, 2022 - December 23, 2012
Hearing on Patient Safety and Quality Issues in End Stage Renal Disease
-
psnet.ahrq.gov/issue/safe-practices-reduce-cpoe-alert-fatigue-through-monitoring-analysis-and-optimization
February 17, 2021 - WebM&M Cases
Overdose of Gabapentin and Oxycodone in a Patient with End-Stage Renal
-
psnet.ahrq.gov/node/33669/psn-pdf
May 01, 2018 - products warn prescribers of problems related to total drug
dose, duplicate therapy, patient weight, renal … target goals, and
subsequently expanded our study to include several dozen medications affected by renal
-
psnet.ahrq.gov/web-mm/bowel-prep
March 01, 2017 - Oral sodium phosphate preparations should not be used in patients with renal disease, congestive heart … if the patient has one of the medical conditions that would preclude the use of this agent, such as renal … contraindications of sodium phosphate preparations; institutions with a high prevalence of cardiac and renal
-
psnet.ahrq.gov/issue/fair-and-reliable-medical-justice-act
March 06, 2005 - October 31, 2012
Hearing on Patient Safety and Quality Issues in End Stage Renal Disease
-
psnet.ahrq.gov/issue/prescribing-errors-low-molecular-weight-heparins
July 26, 2017 - study identified prescribing errors – primarily lack of dosage adjustment for body weight and/or renal
-
psnet.ahrq.gov/issue/medication-errors-antituberculosis-therapy-inpatient-academic-setting-forgotten-not-gone
April 27, 2016 - The most common errors were due to inadequate dosing adjustments for weight, renal insufficiency, or
-
psnet.ahrq.gov/issue/excess-dosing-antiplatelet-and-antithrombin-agents-treatment-non-st-segment-elevation-acute
November 10, 2015 - directed at vulnerable populations such as elderly patients with specific comorbidities (eg, diabetes, renal